Titan Pharmaceuticals Stock Price Prediction
| TTNP Stock | USD 7.32 0.22 3.10% |
Oversold Vs Overbought
51
Oversold | Overbought |
Titan Pharmaceuticals stock price prediction is an act of determining the future value of Titan Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Titan Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Titan Pharmaceuticals and does not consider all of the tangible or intangible factors available from Titan Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Titan Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Titan Pharmaceuticals' stock price prediction:Wall Street Target Price 7 | Quarterly Revenue Growth (1.00) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Titan Pharmaceuticals based on different types of headlines from major news networks to social media. The Titan stock price prediction module provides an analysis of price elasticity to changes in media outlook on Titan Pharmaceuticals over a specific investment horizon. Using Titan Pharmaceuticals hype-based prediction, you can estimate the value of Titan Pharmaceuticals from the perspective of Titan Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Titan Pharmaceuticals using Titan Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Titan using crowd psychology based on the activity and movement of Titan Pharmaceuticals' stock price.
Titan Pharmaceuticals Implied Volatility | 0.0 |
Titan Pharmaceuticals' implied volatility exposes the market's sentiment of Titan Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Titan Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Titan Pharmaceuticals stock will not fluctuate a lot when Titan Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Titan Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Titan Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Titan because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Titan Pharmaceuticals after-hype prediction price | USD 7.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Titan |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Titan Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Titan Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Titan Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Titan Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Titan Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Titan Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Titan Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Titan Pharmaceuticals' historical news coverage. Titan Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.58 and 13.50, respectively. We have considered Titan Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Titan Pharmaceuticals is relatively risky at this time. Analysis and calculation of next after-hype price of Titan Pharmaceuticals is based on 3 months time horizon.
Titan Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Titan Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Titan Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Titan Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.38 | 6.36 | 0.07 | 0.10 | 6 Events / Month | 5 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
7.32 | 7.04 | 0.85 |
|
Titan Pharmaceuticals Hype Timeline
Titan Pharmaceuticals is at this time traded for 7.32. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.1. Titan is estimated to decline in value after the next headline, with the price expected to drop to 7.04. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.85%, whereas the daily expected return is at this time at 0.38%. The volatility of related hype on Titan Pharmaceuticals is about 2312.73%, with the expected price after the next announcement by competition of 7.22. About 45.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.0. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Titan Pharmaceuticals recorded a loss per share of 7.41. The entity last dividend was issued on the 1st of December 2020. The firm had 1:20 split on the 9th of January 2024. Given the investment horizon of 90 days the next estimated press release will be in about 6 days. Check out Titan Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Titan Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Titan Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Titan Pharmaceuticals' future price movements. Getting to know how Titan Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Titan Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALKS | Alkermes Plc | (0.56) | 11 per month | 0.00 | (0.1) | 2.79 | (4.24) | 21.89 | |
| IRWD | Ironwood Pharmaceuticals | (0.40) | 11 per month | 0.00 | (0.11) | 3.82 | (4.53) | 41.66 | |
| DCPH | Deciphera Pharmaceuticals LLC | (0.12) | 10 per month | 2.48 | 0 | 4.84 | (4.32) | 17.94 | |
| EGRX | Eagle Pharmaceuticals | (0.40) | 10 per month | 4.87 | 0.03 | 8.00 | (7.92) | 23.10 | |
| NBIX | Neurocrine Biosciences | 0.09 | 12 per month | 0.00 | (0.09) | 2.51 | (2.36) | 6.58 | |
| DVAX | Dynavax Technologies | (0.26) | 9 per month | 0.00 | (0.21) | 2.50 | (2.90) | 6.78 |
Titan Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Titan price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Titan using various technical indicators. When you analyze Titan charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Titan Pharmaceuticals Predictive Indicators
The successful prediction of Titan Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Titan Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Titan Pharmaceuticals based on analysis of Titan Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Titan Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Titan Pharmaceuticals's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.001708 | 0.001518 | Price To Sales Ratio | 33.72 | 32.03 |
Story Coverage note for Titan Pharmaceuticals
The number of cover stories for Titan Pharmaceuticals depends on current market conditions and Titan Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Titan Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Titan Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Titan Pharmaceuticals Short Properties
Titan Pharmaceuticals' future price predictability will typically decrease when Titan Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Titan Pharmaceuticals often depends not only on the future outlook of the potential Titan Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Titan Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 752 K | |
| Cash And Short Term Investments | 6.8 M | |
| Shares Float | 700 K |
Check out Titan Pharmaceuticals Basic Forecasting Models to cross-verify your projections. To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Titan Stock analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.41) | Revenue Per Share 0.245 | Quarterly Revenue Growth (1.00) | Return On Assets (0.75) | Return On Equity (1.39) |
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.